ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
DexCom $1.25 billion convertible notes offering and capped call transactions
The 0.375% convertible senior notes are due 2028
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Advent International $2.25 billion Maxar Technologies acquisition financing
We advised the lenders on the facilities
Anglo American $900 million notes offering
The 5.500% senior notes are due 2033
Meta Platforms $8.5 billion senior notes offering
We advised Meta on the investment-grade debt offering
Invacare chapter 11 plan confirmed
We advised the prepetition term loan agent and escrow agent on the transaction
Crestview strategic investment in The Gersh Agency
We advised Crestview Partners on the transaction